Skip to main content
Top
Published in: BMC Cancer 1/2024

Open Access 01-12-2024 | Lung Cancer | Research

The insufficiency of CT examination in early detection of central lung squamous cell carcinoma and squamous epithelial precancerous lesions

Authors: Jiaming Zhou, Bijun Yu, Peng Guo, Shi Wang

Published in: BMC Cancer | Issue 1/2024

Login to get access

Abstract

Background

CT examination for lung cancer has been carried out for more than 20 years and great achievements have been made in the early detection of lung cancer. However, in the clinical work, a large number of advanced central lung squamous cell carcinoma are still detected through bronchoscopy. Meanwhile, a part of CT-occult central lung squamous cell carcinoma and squamous epithelial precancerous lesions are also accidentally detected through bronchoscopy.

Methods

This study retrospectively collects the medical records of patients in the bronchoscopy room of the Endoscopy Department of Zhejiang Cancer Hospital from January 2014 to December 2018. The inclusion criteria for patients includes: 1.Patient medical records completed, 2.Without history of lung cancer before the diagnosis and first pathological diagnosis of primary lung cancer, 3.Have the lung CT data of the same period, 4.Have the bronchoscopy records and related pathological diagnosis, 5.The patients undergoing radical surgical treatment must have a complete postoperative pathological diagnosis. Finally, a total of 10,851 patients with primary lung cancer are included in the study, including 7175 males and 3676 females, aged 22–98 years. Firstly, 130 patients with CT-occult lesions are extracted and their clinical features are analyzed. Then, 604 cases of single central squamous cell carcinoma and 3569 cases of peripheral adenocarcinoma are extracted and compares in postoperative tumor diameter and lymph node metastasis.

Results

115 cases of CT-occult central lung squamous cell carcinoma and 15 cases of squamous epithelial precancerous lesions are found. In the total lung cancer, the proportion of CT-occult lesions is 130/10,851 (1.20%). Meanwhile, all these patients are middle-aged and elderly men with a history of heavy smoking. There are statistically significant differences in postoperative median tumor diameter (3.65 cm vs.1.70 cm, P < 0.0001) and lymph node metastasis rate (50.99% vs.13.06%, P < 0.0001) between 604 patients with operable single central lung squamous cell carcinoma and 3569 patients with operable peripheral lung adenocarcinoma. Of the 604 patients with squamous cell carcinoma, 96.52% (583/604) are male with a history of heavy smoking and aged 40–82 years with a median age of 64 years.

Conclusions

This study indicates that the current lung CT examination of lung cancer is indeed insufficiency for the early diagnosis of central squamous cell carcinoma and squamous epithelial precancerous lesions. Further bronchoscopy in middle-aged and elderly men with a history of heavy smoking can make up for the lack of routine lung CT examination.
Literature
1.
go back to reference Hyuna Sung J, Ferlay RL, Siegel, Global Cancer Statistics. 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.CA Cancer J Clin. 2021;71(3):209–249.10.3 322/caac.21660. Hyuna Sung J, Ferlay RL, Siegel, Global Cancer Statistics. 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.CA Cancer J Clin. 2021;71(3):209–249.10.3 322/caac.21660.
6.
go back to reference Le Ju-Fang Shi N, Wu et al. Clinical characteristics and medical service utilization of lung cancer in China, 2005–2014: overall design and results from a multicenter retrospective epidemiologic survey.Lung Cancer. 2019;128:91–10010.1016/j.lungcan.2018.11.031. Le Ju-Fang Shi N, Wu et al. Clinical characteristics and medical service utilization of lung cancer in China, 2005–2014: overall design and results from a multicenter retrospective epidemiologic survey.Lung Cancer. 2019;128:91–10010.1016/j.lungcan.2018.11.031.
11.
go back to reference Travis WD et al. Brambilla E,Burke APWHO classification of tumours of the lung,pleura,thymus and heart [M].4th.Lyon:IARC Press,2015:153–181. Travis WD et al. Brambilla E,Burke APWHO classification of tumours of the lung,pleura,thymus and heart [M].4th.Lyon:IARC Press,2015:153–181.
14.
go back to reference Chinese AntiCancer Association, Lung Cancer Study Group of Committee of Oncopathology; Multicenter Big Data Research Project Specialists of Chinese Lung Cancer Pathology. Current status of postoperative pathological diagnosis of lung cancer in China: a multicenter big data study. Zhonghua Bing Li Xue Za Zhi [J]. 2021;50(8):882–90. https://doi.org/10.3760/cma.j.cn112151-20210427-00328.CrossRef Chinese AntiCancer Association, Lung Cancer Study Group of Committee of Oncopathology; Multicenter Big Data Research Project Specialists of Chinese Lung Cancer Pathology. Current status of postoperative pathological diagnosis of lung cancer in China: a multicenter big data study. Zhonghua Bing Li Xue Za Zhi [J]. 2021;50(8):882–90. https://​doi.​org/​10.​3760/​cma.​j.​cn112151-20210427-00328.CrossRef
16.
go back to reference Zhang Y, Vaccarella S. Global variations in lung cancer incidence by histological subtype in 2020: a population-based study. Lancet Oncol. 2023;24(11):1206–18. -2045(23)00444-8.CrossRefPubMed Zhang Y, Vaccarella S. Global variations in lung cancer incidence by histological subtype in 2020: a population-based study. Lancet Oncol. 2023;24(11):1206–18. -2045(23)00444-8.CrossRefPubMed
19.
go back to reference Jonsson S, Franklin WA, Varella-Garcia M, et al. Prevalence, molecular markers, and outcome of bronchial squamous carcinoma in situ in high-risk subjects. APMIS. 2023;131:513–27.CrossRefPubMed Jonsson S, Franklin WA, Varella-Garcia M, et al. Prevalence, molecular markers, and outcome of bronchial squamous carcinoma in situ in high-risk subjects. APMIS. 2023;131:513–27.CrossRefPubMed
26.
go back to reference Sato M, Yamada T, Menju T, Aoyama A, Sato T, Chen F, et al. Virtual-assisted lung mapping: outcome of 100 consecutive cases in a single institute. Eur J Cardiothorac Surg. 2015;47:e131–e9.CrossRefPubMed Sato M, Yamada T, Menju T, Aoyama A, Sato T, Chen F, et al. Virtual-assisted lung mapping: outcome of 100 consecutive cases in a single institute. Eur J Cardiothorac Surg. 2015;47:e131–e9.CrossRefPubMed
27.
29.
go back to reference Jiaming Z Bijun, Yu et al. The predictive value of the change of the number of pixels under diferent CT valueintervals in the CT-occult central lung squamouscell carcinoma and squamous epithelialprecancerous lesions.BMC Pulmonary Medicine. (2023) 23426https://doi.org/10.1186/s12890-023-02732-w. Jiaming Z Bijun, Yu et al. The predictive value of the change of the number of pixels under diferent CT valueintervals in the CT-occult central lung squamouscell carcinoma and squamous epithelialprecancerous lesions.BMC Pulmonary Medicine. (2023) 23426https://​doi.​org/​10.​1186/​s12890-023-02732-w.
Metadata
Title
The insufficiency of CT examination in early detection of central lung squamous cell carcinoma and squamous epithelial precancerous lesions
Authors
Jiaming Zhou
Bijun Yu
Peng Guo
Shi Wang
Publication date
01-12-2024
Publisher
BioMed Central
Published in
BMC Cancer / Issue 1/2024
Electronic ISSN: 1471-2407
DOI
https://doi.org/10.1186/s12885-024-12052-9

Other articles of this Issue 1/2024

BMC Cancer 1/2024 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine